Jon Otterstatter

Independent Trustee

Mr. Otterstatter joined the Board of Trustees in 2018 and was appointed Chairman in June 2021. Most recently he co-founded Preventice Technologies, Inc. and led the company as CEO through the acquisition by Boston Scientific in March of 2021. In addition to the Dakota REIT, Mr. Otterstatter serves on the Board of Directors of Protenus, metroConnections, Cyber Advisors and Sibel Health.